PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 116 filers reported holding PROVENTION BIO INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,267 | +190.1% | 509 | +27.2% | 0.00% | +100.0% |
| Q4 2022 | $4,228 | +111.4% | 400 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -50.0% | 400 | -63.3% | 0.00% | -100.0% |
| Q4 2021 | $6,000 | +100.0% | 1,090 | +172.5% | 0.00% | – |
| Q3 2021 | $3,000 | -57.1% | 400 | -53.7% | 0.00% | -100.0% |
| Q2 2021 | $7,000 | -41.7% | 864 | -21.5% | 0.00% | -80.0% |
| Q1 2021 | $12,000 | -29.4% | 1,100 | +10.0% | 0.01% | -37.5% |
| Q4 2020 | $17,000 | +30.8% | 1,000 | 0.0% | 0.01% | +60.0% |
| Q3 2020 | $13,000 | +18.2% | 1,000 | +25.0% | 0.01% | 0.0% |
| Q2 2020 | $11,000 | +57.1% | 800 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $7,000 | -53.3% | 800 | -20.0% | 0.00% | -50.0% |
| Q4 2019 | $15,000 | +200.0% | 1,000 | +25.0% | 0.01% | +200.0% |
| Q3 2019 | $5,000 | +400.0% | 800 | +700.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |